Overview
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare type of non-Hodgkin lymphoma characterized by infiltration of the subcutaneous fat tissue, often mimicking inflammatory panniculitides such as lupus erythematosus panniculitis (LEP). 1Diagnosis
Histopathology: Infiltration of the panniculus, predominantly involving fat, periadnexial, and perivascular structures consistent with lymphocytic lobular panniculitis (LLP). 1
Immunophenotyping: Essential for distinguishing SPTCL from other conditions like LEP by identifying T-cell markers. 1
Clinical Presentation: High fever, malaise, nausea, vomiting, and subcutaneous nodules or ulcerating lesions, particularly on lower extremities. 1Management
First-line Treatment: Antitumor chemotherapy regimens such as CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) or modified CHOP. Specific dosing details not provided in the abstract. 1
Adjunctive Therapies: Management of associated conditions like macrophage activation syndrome may require immunomodulatory or immunosuppressive agents, though specific recommendations are not detailed in the abstract. 1Special Populations
Comorbidities: Case reports suggest careful consideration of comorbidities like macrophage activation syndrome, which may influence treatment approaches. 1Key Recommendations
Perform comprehensive histopathology and immunophenotyping to differentiate SPTCL from inflammatory panniculitides like LEP. (Evidence: Moderate) 1
Consider first-line chemotherapy regimens such as CHOP for treating SPTCL, tailored to patient-specific factors. (Evidence: Expert opinion) 1
Closely monitor and manage associated systemic complications, such as macrophage activation syndrome, alongside lymphoma treatment. (Evidence: Weak) 1References
1 Gonzalez EG, Selvi E, Lorenzini S, Maggio R, Mannucci S, Galeazzi M et al.. Subcutaneous panniculitis-like T-cell lymphoma misdiagnosed as lupus erythematosus panniculitis. Clinical rheumatology 2007. link